Regional variation and cost implications of prescribed extended half‐life factor concentrates among U.S. Haemophilia Treatment Centres for patients with moderate and severe haemophilia

Overview of attention for article published in Haemophilia, April 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#38 of 1,629)
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 3 news outlets

twitter: 3 X users

Citations

dimensions_citation: 38 Dimensions

Readers on

mendeley: 36 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 3 news stories from 3 outlets.

Recent Developments in Hemophilia: Hemophilic Arthopathy and Pain

Medical Health News, 17 May 2019

One severe complication of hemophilia is that of repeated joint bleeding, ultimately resulting in impairment of the joint and…

Recent Developments in Hemophilia: Hemophilic Arthopathy and Pain

MedPage Today, 17 May 2019

One severe complication of hemophilia is that of repeated joint bleeding, ultimately resulting in impairment of the joint and…

Extended half-life clotting factors cut infusions, hike prices

Pediatric News , 23 Apr 2019

More than a fifth of patients with hemophilia may now be using extended half-life (EHL) clotting factors, although the economic…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.